Related Experiment Videos
Antiinflammatory effects of oxatomide.
G Marone1, F Granata, G Spadaro
1Department of Medicine, School of Medicine, University of Naples Federico II, Italy.
Journal of Investigational Allergology & Clinical Immunology
|October 8, 1999
Summary
Oxatomide, an H1 antagonist, demonstrates anti-inflammatory effects by inhibiting mediators from various immune cells. This broadens its therapeutic potential beyond allergies to other inflammatory conditions.
Area of Science:
- Immunology
- Pharmacology
Background:
- Histamine exhibits broader proinflammatory and immunomodulatory roles than previously understood.
- Histamine influences lymphocyte, monocyte, basophil, and macrophage functions, modulating inflammatory mediator and cytokine release.
Purpose of the Study:
- To investigate the anti-inflammatory properties of oxatomide, a histamine H1 receptor antagonist.
- To explore oxatomide's effects on inflammatory mediator release from various human inflammatory cells.
Main Methods:
- In vitro studies using human basophils, mast cells, and neutrophils.
- Assessing the inhibition of preformed and de novo synthesized inflammatory mediators.
- Evaluating the impact on arachidonic acid mobilization and synthesis of leukotriene B4 and platelet-activating factor.
Main Results:
- Oxatomide inhibited the release of histamine, tryptase, leukotriene C4, and prostaglandin D2 from basophils and mast cells.
- Oxatomide also inhibited neutrophil inflammatory mediator synthesis, including leukotriene B4 and platelet-activating factor.
- The drug's effects are likely mediated by reducing cytosolic phospholipase A2 activity in neutrophils.
Conclusions:
- Oxatomide possesses anti-inflammatory activities extending beyond H1 receptor antagonism.
- These broader pharmacological actions on inflammatory cells support its efficacy in allergic and inflammatory disorders like urticaria, allergic rhinitis, and asthma.